About Pharma Industry

BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.

Novo Nordisk Exec Charged With Insider Trading; Cash Stashed in Caribbean

By Jim Edwards | Sep 4, 2009

A Novo Nordisk executive was fired and is being held on remand for alleged insider trading in the company’s stock, according to the Copenhagen Post. He garnered 6 million kroner by trading on Novo stock, stashing the riches in an offshore account in the Caribbean. Prosecutors declined to name the man, who is 35 years old, but said:

The trading was conducted by a person in a position of trust, it was professionally carried out and it occurred systematically over a number of years, resulting in a huge payoff.

Novo said the man was not a member of senior management:

The employee does not have managerial responsibility, but has had access to information.

Perhaps he set up his island bank account when he went on this Novo cruise to St. Thomas in March, as described by Iguana Bio:

Novo Nordisk, the global insulin-maker behemoth, is sending 3,000 of its workers down to St. Thomas aboard the VERY nice Royal Caribbean Liberty of the Sea. The 5-day long PARTAAAYY, err “training workshop” is underway as we speak.

Or perhaps his motivation was Novo’s relatively modest compensation program.

Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University's business and journalism schools. Follow him on Twitter or send him an email.

BNET User Analysis

Web Buzz:
  • Biotech Stocks: Sanofi, Novo Nordisk lower on drug-safety worries

    MarketWatch - 150 days 16 hours 43 minutes ago

    Drug stocks trade mixed as European drugmakers Sanofi-Aventis and Novo Nordisk A/S lose ground amid safety concerns about their respective insulin products.

  • Merrion signs $58M deal with Novo Nordisk

    Bizjournals - 308 days 16 hours 37 minutes ago

    Merrion Pharmaceuticals, an Irish drug company with a small Wilmington outpost, has signed a drug development deal with Novo Nordisk. Merrion could receive as much as $58 million to develop an oral form of a Novo Nordisk drug. The pay to the company will be come from milestone payments and royalties on sales. Novo Nordisk also will buy 3 million...

  • Merrion forges tech deal with Novo Nordisk

    FierceMarkets - 311 days 15 hours 7 minutes ago

    Ireland's Merrion Pharmaceuticals has forged a new deal to use its technology to develop an oral formulation of Novo Nordisk's proprietary GLP-1 receptor agonist. And the biotech company announced that Novo Nordisk will pay out up to $58 million in milestone payments through an approval. Novo Nordisk, which specializes in diabetes drugs, also...

  • FDA delays feedback on Novo's Victoza

    FierceMarkets - 61 days 19 hours 31 minutes ago

    Novo Nordisk said today that the FDA has delayed feedback on its much-anticipated diabetes drug Victoza (liraglutide) until the fourth quarter of this year. The company had predicted a positive response from the agency by this month. "Novo Nordisk continues the constructive dialog with the FDA regarding the regulatory process for liraglutide,"...

  • jp.dk - Novo Nordisk cuts hundreds of jobs

    PharmaGossip - 12 days 1 hour 36 minutes ago

    Novo Nordisk cuts hundreds of jobs Published 11.11.09 13:20 Nation’s leading pharmaceutical company’s closing of production plant in Kalundborg affects over 300 jobs Pharmaceutical company Novo Nordisk is shutting down one of its insulin-producing facilities in the Zealand town of Kalundborg, a move that will result in 330 positions......

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement